Three independently isolated X-linked suppressors of the dominant masculinizing
her-1 allele
n695 (Burgess et al., WBG 9.2, 1986) are large X-chromosome duplications (Tanner et al. C. elegans Meeting Abstracts 1989) that result in a high incidence of XO lethality with the surviving XO worms variably transformed toward hermaphrodite. The endpoints of these duplications have now been more precisely mapped by quantitative Southern blotting and each has been shown to include the
sdc-2 locus. All three,
ct28,
ct30, and
ct31 have left endpoints between
xol-1 and
lin-14. On the right
ct30 terminates between
myo-2 and
unc-3, while
ct28 and
ct31 terminate between
unc-3 and
let-2. Thus
ct30 can be estimated to duplicate between 14% and 51% of the X chromosome;
ct31 and
ct28 between 24% and 54%.
ct31 has been shown genetically not to include Unc-15, and therefore does not include sdc- 1. All three duplications result in virtually indistinguishable phenotypes although they probably duplicate different amounts of the X chromosome. XO animals, carrying one copy of the duplication, are non- mating, slow-growing, and variably feminized. Nomarski observation of 140
ct31 XO and
ct31 lon-2(
e678) XO animals showed that 77% had defective tails, 18% had a mid-ventral hypodermal protrusion, 16% had a sac-like or a two-armed gonad, and 8% contained oocytes. Immunofluorescent staining of 193
ct31 XO animals with an anti- vitellogenin antibody indicated 11% (21 animals) produced yolk protein. Three
ct31 XO animals have been observed to contain developing embryos. Homozygous
ct28,
ct30. and
ct31 XX animals carrying two copies of the duplication are slow-growing Dumpy hermaphrodites. This phenotype is very different from that of animals carrying mnDp10, another large homozygous-viable X-chromosome duplication ( between 22% and 38% of the X chromosome), that includes much of the same region as
ct28,
ct30, and
ct31 but does not include
sdc-2. XO animals homozygous for mnDp10 are healthy mating males, although their fertility is reduced. XX animals homozygous for mnDp10 are perhaps very slightly dumpy but grow normally. These observations and the apparently different sizes of
ct28,
ct30, and
ct31 suggest that their resulting phenotypes are not due simply to increased X-chromosome dosage, but rather to the duplication of specific sequences. In addition to feminizing XO animals, the
ct31 duplication results in significant XO lethality. The ratio of XO to XX cross progeny counted in two separate crosses was 226/399, indicating 43% XO lethality. This lethality is XO specific since the self progeny of
ct31 homozygous hermaphrodites show only 5% lethality. Similar experiments with
ct28 and
ct30 are in progress. We suggest that the feminization and reduced viability of XO animals containing these duplications is due primarily to increased copy number of
sdc-2. Loss-of-function alleles of
sdc-2 result in masculinization of XX animals, XX lethality and increased X-chromosome expression (Genetics 122; 579-593, 1989). If
sdc-2 is a developmental switch gene, the gain-of-function phenotype should be hermaphroditization of XO animals, XO lethality and reduced X chromosome expression, as predicted by Nusbaum and Meyer (ibid.). Previous results from this lab indicate that the X-linked duplications affect X-chromosome expression, suggesting effects on dosage compensation as well as sexual phenotype. The
ct31 duplication increases the penetrance of the hypomorphic
lin-15 allele
n765, consistent with a general decrease in X expression caused by
ct31 ( Burgess et al. WBG 9.2, 1986). RNA dot-blot analyses indicated a slightly higher level (1.24x) of
myo-2 mRNA in
ct31 than in wild type. Since the
ct31 strain has four copies of
myo-2 compared to two copies in N2, this result may still reflect a reduction of X-chromosome expression. Further analysis of dosage compensation effects of
ct28,
ct30 and
ct31 is in progress, as are experiments on the results of specifically varying
sdc-2(+) dosage in the presence of these duplications.